Mutants and pseudorevertants of Moloney murine leukemia virus with alterations at the integration site.
about
HIV-1 reverse transcriptionCoupled integration of human immunodeficiency virus type 1 cDNA ends by purified integrase in vitro: stimulation by the viral nucleocapsid proteinIsolation and analysis of retroviral integration targets by solo long terminal repeat inverse PCRIsolation of cellular promoters by using a retrovirus promoter trap.Effects of 3' untranslated region mutations on plus-strand priming during moloney murine leukemia virus replication.Integration of the hybrid adenoretroviral vector AdLTR-luc involves both MoMLV elements flanking the transgene.Retroviral DNA integration.Effect of polypurine tract (PPT) mutations on human immunodeficiency virus type 1 replication: a virus with a completely randomized PPT retains low infectivity.Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses.Substrate sequence selection by retroviral integrase.Integration of mini-retroviral DNA: a cell-free reaction for biochemical analysis of retroviral integration.Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae.Profile of Stephen P. Goff. Interview by Greg WilliamsCatalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residuesMutations in the U5 sequences adjacent to the primer binding site do not affect tRNA cleavage by rous sarcoma virus RNase H but do cause aberrant integrations in vivoRetroviral Integrase Structure and DNA Recombination MechanismRNA sequences in the Moloney murine leukemia virus genome bound by the Gag precursor protein in the yeast three-hybrid system.Crystal structures of oligonucleotides including the integrase processing site of the Moloney murine leukemia virus.Cheminformatics methods for novel nanopore analysis of HIV DNA terminiA stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vitroMurine leukemia viruses: objects and organisms.MuLV IN mutants responsive to HDAC inhibitors enhance transcription from unintegrated retroviral DNA.Characterization of recombinant murine leukemia virus integrase.Sequences in the human immunodeficiency virus type 1 U3 region required for in vivo and in vitro integration.Characterization of chimeras between the ecotropic Moloney murine leukemia virus and the amphotropic 4070A envelope proteins.Concerted integration of linear retroviral DNA by the avian sarcoma virus integrase in vitro: dependence on both long terminal repeat terminiInterference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4.Functional domains of Moloney murine leukemia virus integrase defined by mutation and complementation analysisFunctional identification of nucleotides conferring substrate specificity to retroviral integrase reactions.Clinical applications involving CNS gene transfer.Methods for gene transfer to the central nervous system.Retroviral integrase domains: DNA binding and the recognition of LTR sequences.Second site mutation in the virus envelope expands the host range of a cytopathic variant of Moloney murine leukemia virus.Rous sarcoma virus (RSV) integration in vivo: a CA dinucleotide is not required in U3, and RSV linear DNA does not autointegrate.Genetic analysis of the human immunodeficiency virus type 1 integrase protein.A domain of murine retrovirus surface protein gp70 mediates cell fusion, as shown in a novel SC-1 cell fusion systemAn integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.Role of the His-Cys finger of Moloney murine leukemia virus integrase protein in integration and disintegrationInfluence of substrate structure on disintegration activity of Moloney murine leukemia virus integraseMutational analysis of the carboxyl terminus of the Moloney murine leukemia virus integration protein
P2860
Q27023387-67C4257B-3E6B-4501-93AE-B73575EE51D4Q30453495-7801EF7F-69DB-4A14-9595-E893B752D4D7Q30703613-159DD19C-CD30-43B8-B31F-61D069C4EA1DQ33582024-D80085F8-219C-440B-8794-3500C243C089Q33640102-89A8CBBE-6F1F-45E4-B9C5-6238D9C924CAQ33754706-D5CC1822-0E08-48AA-94F0-5473548CAB37Q33787076-62842054-0C59-4FBA-8C09-D29EFC8FE251Q33788773-86A70135-B269-40A7-A0C7-06D5EF6B5A63Q33796518-2AA0A114-6853-443F-AFA7-5DA02C2230CFQ33836258-798EF264-B843-4748-91B9-FD31FC2E8BCFQ33852223-62046ACC-2958-472C-AF42-29298F9B3C03Q33932483-ED0022C8-2439-4F18-8ACC-E10B518878ABQ34154460-A557632D-27D1-4068-A9A1-9E33252B6599Q34181199-D306E373-565A-48BE-ABB3-A1C281F04A4AQ34232962-41FC91AD-A669-4C98-A630-8C870FF61049Q34668065-4C4F61AD-3CCC-4380-8EF2-E4B60B313275Q35122730-976500E5-5D03-4BB3-ABED-00A0E522C1B9Q35130587-89C80E0E-3537-4338-81EE-8C608D9485E4Q35197733-248AE11F-0737-453D-BAC2-88D30E9A2016Q35628704-089672DF-153C-4F54-8794-F06E5BFD7E86Q35692330-8BC8076E-C4A2-4495-A28E-63DF3AC70841Q35803106-CEEEA1E6-3F06-4C4E-A8CB-7CF6DD92665EQ35830090-2AD1A2C2-F9D8-4AB6-A1E7-30F442B96DC6Q35846606-40D821D3-04A3-4F7D-A299-729F2431A7F8Q35860468-98096E04-ED73-4882-A2D4-B2597566AC28Q35861200-93DCD165-EB2A-4394-A04F-E61388C10EC0Q35861652-29ED2D2D-AB6D-4F72-B042-34191AE29AF4Q35864451-198B65AB-2BB7-43BD-92AA-1E020322E29FQ35876367-54DF409E-7C67-49CF-BFB5-FC124473AD0EQ35899850-0A872E1A-39AC-4B73-9C15-67188B888435Q35902332-8F04AD03-6648-4671-AC12-C5485FB89494Q35914265-D994EA6F-3E49-458D-AE66-9ED35E847360Q36240769-57B71231-6342-4933-8755-5EE39583AF4DQ36423916-F60A74BC-B377-4F95-AD86-ECCC7CA09940Q36629409-B08AC38B-0BD8-4BEC-BF8B-3A406BFD6D0AQ36633550-119FBF52-9B92-49AA-9D11-4317263023D2Q36637774-36EEF1C3-E57D-4229-A041-7F4038831185Q36652266-53B276A5-3EB2-4AEF-96A9-20C72282A436Q36654975-788F7F10-5BF4-4F96-B654-DD9F5C9CF41BQ36684707-7036D19B-C15D-4B1E-ABB5-CAF3B2216BB8
P2860
Mutants and pseudorevertants of Moloney murine leukemia virus with alterations at the integration site.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Mutants and pseudorevertants o ...... tions at the integration site.
@en
Mutants and pseudorevertants o ...... tions at the integration site.
@nl
type
label
Mutants and pseudorevertants o ...... tions at the integration site.
@en
Mutants and pseudorevertants o ...... tions at the integration site.
@nl
prefLabel
Mutants and pseudorevertants o ...... tions at the integration site.
@en
Mutants and pseudorevertants o ...... tions at the integration site.
@nl
P1433
P1476
Mutants and pseudorevertants o ...... tions at the integration site.
@en
P2093
P304
P356
10.1016/0092-8674(85)90114-X
P407
P577
1985-09-01T00:00:00Z